BWAY
Price
$15.85
Change
-$0.12 (-0.75%)
Updated
Sep 5 closing price
Capitalization
295.36M
66 days until earnings call
PXMBF
Price
$3.50
Change
+$0.70 (+25.00%)
Updated
May 16 closing price
Capitalization
191.86M
Interact to see
Advertisement

BWAY vs PXMBF

Header iconBWAY vs PXMBF Comparison
Open Charts BWAY vs PXMBFBanner chart's image
BrainsWay
Price$15.85
Change-$0.12 (-0.75%)
Volume$47.66K
Capitalization295.36M
PAXMAN AB
Price$3.50
Change+$0.70 (+25.00%)
Volume$600
Capitalization191.86M
BWAY vs PXMBF Comparison Chart in %
Loading...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BWAY vs. PXMBF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Buy and PXMBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (BWAY: $15.85 vs. PXMBF: $3.50)
Brand notoriety: BWAY and PXMBF are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BWAY: 78% vs. PXMBF: 100%
Market capitalization -- BWAY: $295.36M vs. PXMBF: $191.86M
BWAY [@Medical/Nursing Services] is valued at $295.36M. PXMBF’s [@Medical/Nursing Services] market capitalization is $191.86M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BWAY’s FA Score shows that 0 FA rating(s) are green whilePXMBF’s FA Score has 0 green FA rating(s).

  • BWAY’s FA Score: 0 green, 5 red.
  • PXMBF’s FA Score: 0 green, 5 red.
According to our system of comparison, BWAY is a better buy in the long-term than PXMBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BWAY’s TA Score shows that 6 TA indicator(s) are bullish.

  • BWAY’s TA Score: 6 bullish, 4 bearish.

Price Growth

BWAY (@Medical/Nursing Services) experienced а +1.86% price change this week, while PXMBF (@Medical/Nursing Services) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

Reported Earning Dates

BWAY is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BWAY($295M) has a higher market cap than PXMBF($192M). BWAY has higher P/E ratio than PXMBF: BWAY (56.61) vs PXMBF (29.27). BWAY YTD gains are higher at: 68.081 vs. PXMBF (0.000). PXMBF has higher annual earnings (EBITDA): 57.5M vs. BWAY (8.3M). PXMBF has more cash in the bank: 153M vs. BWAY (78M). BWAY has less debt than PXMBF: BWAY (6.13M) vs PXMBF (9.54M). PXMBF has higher revenues than BWAY: PXMBF (262M) vs BWAY (46.1M).
BWAYPXMBFBWAY / PXMBF
Capitalization295M192M154%
EBITDA8.3M57.5M14%
Gain YTD68.0810.000-
P/E Ratio56.6129.27193%
Revenue46.1M262M18%
Total Cash78M153M51%
Total Debt6.13M9.54M64%
FUNDAMENTALS RATINGS
BWAY vs PXMBF: Fundamental Ratings
BWAY
PXMBF
OUTLOOK RATING
1..100
4450
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
4675
SMR RATING
1..100
7269
PRICE GROWTH RATING
1..100
3671
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PXMBF's Valuation (72) in the null industry is in the same range as BWAY (77) in the Medical Specialties industry. This means that PXMBF’s stock grew similarly to BWAY’s over the last 12 months.

BWAY's Profit vs Risk Rating (46) in the Medical Specialties industry is in the same range as PXMBF (75) in the null industry. This means that BWAY’s stock grew similarly to PXMBF’s over the last 12 months.

PXMBF's SMR Rating (69) in the null industry is in the same range as BWAY (72) in the Medical Specialties industry. This means that PXMBF’s stock grew similarly to BWAY’s over the last 12 months.

BWAY's Price Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for PXMBF (71) in the null industry. This means that BWAY’s stock grew somewhat faster than PXMBF’s over the last 12 months.

BWAY's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as PXMBF (100) in the null industry. This means that BWAY’s stock grew similarly to PXMBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BWAYPXMBF
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
9%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
9%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend about 1 month ago
79%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PQJCX14.580.07
+0.48%
PGIM Jennison Small-Cap Core Equity R6
ATHWX21.290.07
+0.33%
American Century Heritage R
AAISX19.370.05
+0.26%
American Beacon International Eq Adv
ERSGX14.380.02
+0.14%
Eaton Vance Small-Cap R
OMSCX25.19-0.09
-0.36%
Invesco Main Street All Cap C

BWAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with CLPT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-0.75%
CLPT - BWAY
34%
Loosely correlated
-0.27%
STIM - BWAY
34%
Loosely correlated
-2.42%
BFLY - BWAY
31%
Poorly correlated
+1.96%
ARAY - BWAY
30%
Poorly correlated
N/A
OFIX - BWAY
29%
Poorly correlated
-1.02%
More

PXMBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PXMBF has been loosely correlated with SRDX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PXMBF jumps, then SRDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXMBF
1D Price
Change %
PXMBF100%
N/A
SRDX - PXMBF
41%
Loosely correlated
-3.02%
BLOZF - PXMBF
23%
Poorly correlated
-0.45%
BWAY - PXMBF
22%
Poorly correlated
-0.75%
ISPC - PXMBF
21%
Poorly correlated
+27.42%
SARTF - PXMBF
7%
Poorly correlated
N/A
More